LeadCare Ultra Blood Lead Test Kit Recalled for Control Test Inaccuracy
Magellan Diagnostics is recalling the LeadCare Ultra Blood Lead Test Kit due to control test failures causing potential underestimation of blood lead levels in patient samples. The recall involves 441 kits with worldwide distribution.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall. The rubric specifies that FDA Class I recalls must score no lower than 4. No deaths or serious injuries have been reported in the recall notice, which would be required for a Critical (5) rating. Therefore, the appropriate severity is 4 (Severe).
Plain-English summary
Magellan Diagnostics, Inc. is recalling the LeadCare Ultra Blood Lead Test Kit (Catalog Number 70-8098). The company received reports that control tests—either the Low-Control or High-Control—are generating low results, which may cause the underestimation of blood lead levels in patient samples.
The recall affects 441 kits containing 192 tests per kit, totaling 84,672 tests. The affected lot numbers and expiration dates are 2011MU (25 MAR 22), 2104MU (25 AUG 22), and 2108MU (31 MAR 22). The kits have been distributed worldwide, including the US, Puerto Rico, Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and the Philippines.
The recalled product
- Product
- LeadCare Ultra Blood Lead Test Kit Catalog Number 70-8098
- Manufacturer
- Magellan Diagnostics, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 2108MU - 31MAR22.
Distribution
Part of a larger recall action
This product is one of 3 recalled by Magellan Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Magellan Diagnostics, Inc.
See all →- HighLeadCare Plus Blood Lead Test Kit Recalled for Unexpectedly Elevated Results
FDA (Devices) · 2026-04-29
- ModerateLeadCare Ultra Blood Lead Test Kit Recalled for False Positive Results
FDA (Devices) · 2026-04-29
- ModerateLeadCare II Blood Lead Test Kit Recall for Inaccurate Results
FDA (Devices) · 2026-04-29
- HighBlood lead test kits recalled over mislabeled calibration buttons
FDA (Devices) · 2025-12-03
- HighBlood Lead Test Kits Recalled for Defective Treatment Reagent Caps
FDA (Devices) · 2023-11-15
Same hazard · inaccurate test results
See all →- HighBeckman Coulter Access Total T4 Calibrator Recalled for Inaccurate Results
FDA (Devices) · 2026-04-29
- HighAccess Testosterone assay Catalog Number 33560 recalled
FDA (Devices) · 2025-06-11
- HighBeckman Coulter Sample Probes with Defective Tips Clinical Chemistry
FDA (Devices) · 2025-06-11
- ModerateBeckman Coulter Sample Probe Manufacturing Defect Recall
FDA (Devices) · 2025-06-11
- LowApo B Reagent calibration error may produce inaccurate test results
FDA (Devices) · 2025-06-04